- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 27.09. | Sanofi's Dupixent scores double COPD win in US, China | ||
| 27.09. | Roche's PNH drug PiaSky backed for NHS use by NICE | ||
| 27.09. | BMS ends decades-long drought in novel schizophrenia drugs | ||
| 27.09. | World leaders seek 10% cut in antibiotic resistance deaths | ||
| 27.09. | Vicebio raises $100m for vaccines and other bio financings | ||
| 26.09. | Mirai Bio launches with plan to help genetic med developers | ||
| 26.09. | AZ gets sought-after lung cancer approval for Tagrisso | ||
| 26.09. | Second Niemann-Pick approval brings more hope to patients | ||
| 26.09. | Obesity drug developer BioAge raises $198m in IPO | ||
| 26.09. | Pfizer pulls sickle cell med Oxbryta off market after deaths | ||
| 26.09. | MSD hits a hurdle with its LAG-3 programme | ||
| 25.09. | Aurion launches eye disease cell therapy in its first market | ||
| 25.09. | Novo Nordisk CEO reticent on lowering semaglutide prices | ||
| 25.09. | Surfing on new Duchenne data, Wave charges $175m offering | ||
| 25.09. | Lilly gets second approval, in Japan, for Alzheimer's drug | ||
| 25.09. | AI firm Generate signs $1bn discovery deal with Novartis | ||
| 24.09. | MHRA's AI as medical device pilot opens for applicants | ||
| 24.09. | Astellas claims EU okay for first claudin 18.2 cancer drug | ||
| 24.09. | UCB, Biogen lupus drug scores in phase 3 trial | ||
| 24.09. | Roche launches 'revolutionary' pathogen detection tech | ||
| 24.09. | Ipsen crosses EU finish line with Alagille syndrome drug | ||
| 23.09. | FDA clears RHYTHM AI's new algorithm for atrial fibrillation | ||
| 23.09. | Sanofi's Sarclisa gets one up on rival Darzalex in myeloma | ||
| 23.09. | FDA clears first drug for Niemann-Pick disease | ||
| 23.09. | J&J tries to push talc bankruptcy over the line once again |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
